Skip to content

Tegress Implant Needle

by C. R. Bard, Inc.

510(k) K050688

Tegress Implant Needle is a medical device (FDA Class II; FDA product code FBK, Endoscopic Injection Needle, Gastroenterology-Urology) made by C. R. Bard, Inc., cleared under FDA 510(k) K050688 on 6 Apr 2005, active as of 22 Oct 2026.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK050688 Date6 Apr 2005ClearedStatusActive

Official records

From the FDA record

Received by the FDA
17 Mar 2005
FDA decision
6 Apr 2005 (Substantially Equivalent)
FDA review time
20 days from receipt to decision
Public document
510(k) summary on file with the FDA

From the FDA 510(k) record K050688 (openFDA), as read on 22 Oct 2026. Quoted as published, gaps included; nothing on this list is generated.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
FBK
FDA applicant
C.R. Bard, Inc.
Device class
Class II
Regulation
21 CFR Part 876.1500
Advisory committee
Gastroenterology, Urology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code FBK (Endoscopic Injection Needle, Gastroenterology-Urology).

Other devices from C. R. Bard, Inc.

See all devices from C. R. Bard, Inc. →